1. scary stuff--why isn't FDA doing more?
    concerned patient concerned patient United States says:
    June 14, 2011 at 5:38 AM

    It is very concerning that the FDA hasn't required a further investigation of SPIRIVA, which contains the same tiotropium as respiramat, just using a different mode of delivery.  Prior studies suggested there may be some increased risk of cardiac events including deaths and now the European data is also suggesting this via the new inhalation device, respiramat with the SAME medication.

    Would love an explanation from the FDA why there isn't further required study of safety of tiotropium dispensed via handihaler, sold as Spiriva in the US.

    Reply
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback